Gary P. Kobinger, Ph.D.
Head of Special Pathogens, Head, Vector Design and Immunotherapy, Special Pathogens Program, National Microbiology Labororatory, Public Health Agency of Canada
Adjunct Professor, Department of Medical Microbiology, Faculty of Medicine, University of Manitoba.
Degrees: B.Sc. Laval University, QC, 1993: Ph.D., University of Montreal, QC, 1998. Post-doctoral training, University of Pennsylvania, Philadephia, 1999-2003.
Telephone: (204) 784-5923
Lab: (204) 784-5935
Fax: (204) 789-2140
The Special Pathogens Program provides Canada’s diagnostic and reference services for risk group 4 (RG4) pathogens. Field and surveillance support is also made available nationally and occasionally internationally. Innovative research on RG4 pathogens as well as training of graduate students, post-doctoral fellows and international partners are additional important focuses of the program. Research interests include investigations on the molecular biology, epidemiology, pathogenesis and host immune responses of RG4 pathogens as well as the development of clinical modalities to cure or prevent infections (e.g. antivirals, vaccines etc.). Developing sensitive and specific diagnostic tests and systems to detect and monitor RG4 pathogens is also a priority, including approaches that can be used successfully in field studies and outbreak settings.